{"version":"1.0","type":"link","title":"Pharmacodynamics of Camizestrant Treatment in Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer: Results From the Randomized, Presurgical SERENA-3 Study.","author_name":"Robertson JFR 외","author_url":"https://prs-insight.online/author/Robertson%20JFR","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/80439","thumbnail_width":1200,"thumbnail_height":630}